US Bancorp’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,001
| Closed | -$2.42K | – | 4170 |
|
|
2025
Q1 | $2.42K | Hold |
3,001
| – | – | ﹤0.01% | 3819 |
|
|
2024
Q4 | $4.14K | Hold |
3,001
| – | – | ﹤0.01% | 3691 |
|
|
2024
Q3 | $3.12K | Hold |
3,001
| – | – | ﹤0.01% | 3674 |
|
|
2024
Q2 | $5.19K | Buy |
+3,001
| New | +$5.19K | ﹤0.01% | 3487 |
|
|
2023
Q4 | – | Sell |
-260
| Closed | -$972 | – | 3967 |
|
|
2023
Q3 | $972 | Buy |
+260
| New | +$972 | ﹤0.01% | 3747 |
|
|
2023
Q2 | – | Sell |
-285
| Closed | -$1.95K | – | 3972 |
|
|
2023
Q1 | $1.95K | Sell |
285
-1,000
| -78% | -$6.84K | ﹤0.01% | 3742 |
|
|
2022
Q4 | $10.2K | Sell |
1,285
-43
| -3% | -$341 | ﹤0.01% | 3281 |
|
|
2022
Q3 | $13K | Buy |
1,328
+43
| +3% | +$421 | ﹤0.01% | 3240 |
|
|
2022
Q2 | $9K | Sell |
1,285
-2,083
| -62% | -$14.6K | ﹤0.01% | 3370 |
|
|
2022
Q1 | $44K | Sell |
3,368
-473
| -12% | -$6.18K | ﹤0.01% | 2683 |
|
|
2021
Q4 | $61K | Buy |
3,841
+400
| +12% | +$6.35K | ﹤0.01% | 2534 |
|
|
2021
Q3 | $55K | Sell |
3,441
-1,965
| -36% | -$31.4K | ﹤0.01% | 2589 |
|
|
2021
Q2 | $75K | Buy |
5,406
+2,566
| +90% | +$35.6K | ﹤0.01% | 2454 |
|
|
2021
Q1 | $41K | Hold |
2,840
| – | – | ﹤0.01% | 2669 |
|
|
2020
Q4 | $49K | Hold |
2,840
| – | – | ﹤0.01% | 2506 |
|
|
2020
Q3 | $52K | Buy |
2,840
+215
| +8% | +$3.94K | ﹤0.01% | 2356 |
|
|
2020
Q2 | $47K | Buy |
+2,625
| New | +$47K | ﹤0.01% | 2406 |
|
|
2017
Q4 | – | Sell |
-10
| Closed | – | – | 3602 |
|
|
2017
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 3576 |
|